Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Board of Directors of Tatneft recommended dividends

11/21/23 TATN

Segezha Group starts production of three-layer plywood 3-PLY ST NS

11/21/23 SGZH

EuroTrans raises ₽13.5 billion in its IPO

11/21/23 EUTR

ITS suspended trading until the launch of its own infrastructure

11/21/23 SPBE

Cian has reported for 9 months of 2023

11/21/23 CIAN

Abrau-Durso continues to open Wine Ateliers in the regions

11/21/23 ABRD

Positive Technologies released a product to protect containerized environments

11/21/23 POSI

Kamaz released the first import-substituted dump truck of K5 generation

11/21/23 KMAZ

Baidu has reported for Q3 2023

11/21/23 BIDU

Shareholders of Rostelecom approved dividends for 2022

11/21/23 RTKM